Please login to the form below

Not currently logged in
Email:
Password:

Idera

This page shows the latest Idera news and features for those working in and with pharma, biotech and healthcare.

Big pharma and biotech M&A activity increases in Q4 2006

530. Idera. Merck. Toll-like Receptor (TLR) agonists. 455. AC Immune. Genentech.

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Deal Watch November 2016 Deal Watch November 2016

    acquisition - company. 235. Idera Pharmaceuticals/ Vivelix Pharmaceuticals. IMO-9200, antagonist of TLR 7, 8 and 9, for non-malignant GI disorders (p1) back ups.

  • Deal Watch November 2015 Deal Watch November 2015

    Option to license. 175. Idera Pharmaceuticals. GlaxoSmithKline. Licence, collaboration. Antisence platform for selected targets in renal disease.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • ImmuneXcite boosts senior leadership ImmuneXcite boosts senior leadership

    He is chairman of the board of Idera Pharmaceuticals and Juniper Pharmaceuticals and has previously worked at Sanofi-Aventis and Genzyme.

  • Idera Pharmaceuticals names new CEO Idera Pharmaceuticals names new CEO

    Idera Pharmaceuticals names new CEO. Vincent Milano was most recently CEO of Viropharma. ... Vincent Milano has been appointed CEO of Idera Pharmaceuticals almost one year after stepping down as CEO of ViroPharma.

  • Former Sanofi SVP to chair Idera Former Sanofi SVP to chair Idera

    Former Sanofi SVP to chair Idera. James Geraghty joins the firm with 20 years biotech experience from Genzyme. ... Idera specialises in developing toll-like receptors (TLRs) for autoimmune and inflammatory conditions and will benefit from Geraghty's

More from appointments
Approximately 2 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics